277 related articles for article (PubMed ID: 8867561)
1. Determinants of the white-coat effect in hypertensive subjects.
Mansoor GA; McCabe EJ; White WB
J Hum Hypertens; 1996 Feb; 10(2):87-92. PubMed ID: 8867561
[TBL] [Abstract][Full Text] [Related]
2. White coat effect in treated hypertensive patients: sex differences.
Myers MG; Reeves RA
J Hum Hypertens; 1995 Sep; 9(9):729-33. PubMed ID: 8551486
[TBL] [Abstract][Full Text] [Related]
3. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
4. Predictors for the white coat effect in general practice patients with suspected and treated hypertension.
Lindbaek M; Sandvik E; Liodden K; Mjell J; Ravnsborg-Gjertsen K
Br J Gen Pract; 2003 Oct; 53(495):790-3. PubMed ID: 14601355
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between body-mass index and white-coat hypertension among referred patients.
Ben-Dov IZ; Mekler J; Ben-Arie L; Bursztyn M
Blood Press Monit; 2007 Apr; 12(2):95-9. PubMed ID: 17353652
[TBL] [Abstract][Full Text] [Related]
6. Comparison between continuous ambulatory arterial blood pressure monitoring and standard blood pressure measurements among patients of younger and older age group.
Babić BK; Bagatin J; Kokić S; Ostojić SB; Carević V; Berović N
Coll Antropol; 2009 Mar; 33(1):65-70. PubMed ID: 19408605
[TBL] [Abstract][Full Text] [Related]
7. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
[TBL] [Abstract][Full Text] [Related]
8. Clinical features, anthropometric characteristics, and racial influences on the 'white-coat effect' in a single-centre cohort of 1553 consecutive subjects undergoing routine ambulatory blood pressure monitoring.
Gualdiero P; Niebauer J; Addison C; Clark SJ; Coats AJ
Blood Press Monit; 2000 Apr; 5(2):53-7. PubMed ID: 10828890
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and predictors of white-coat response in patients with treated hypertension.
MacDonald MB; Laing GP; Wilson MP; Wilson TW
CMAJ; 1999 Aug; 161(3):265-9. PubMed ID: 10463047
[TBL] [Abstract][Full Text] [Related]
10. White-coat hypertension and cardiac organ damage in elderly subjects.
Rizzo V; Cicconetti P; Bianchi A; Lorido A; Morelli S; Vetta F; Salza MC; Marigliano V
J Hum Hypertens; 1996 May; 10(5):293-8. PubMed ID: 8817402
[TBL] [Abstract][Full Text] [Related]
11. Pulse pressure is more susceptible to the white coat effect than is systolic blood pressure: observations from real-life ambulatory blood pressure monitoring.
Ben-Dov IZ; Perk G; Ben-Arie L; Mekler J; Bursztyn M
Am J Hypertens; 2004 Jun; 17(6):535-9. PubMed ID: 15177528
[TBL] [Abstract][Full Text] [Related]
12. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing white-coat effect.
Manios ED; Koroboki EA; Tsivgoulis GK; Spengos KM; Spiliopoulou IK; Brodie FG; Vemmos KN; Zakopoulos NA
Am J Hypertens; 2008 Feb; 21(2):153-8. PubMed ID: 18174883
[TBL] [Abstract][Full Text] [Related]
14. White coat effect and white coat hypertension in pediatric patients.
Matsuoka S; Kawamura K; Honda M; Awazu M
Pediatr Nephrol; 2002 Nov; 17(11):950-3. PubMed ID: 12432440
[TBL] [Abstract][Full Text] [Related]
15. The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study.
Ben-Dov IZ; Kark JD; Mekler J; Shaked E; Bursztyn M
J Hypertens; 2008 Apr; 26(4):699-705. PubMed ID: 18327079
[TBL] [Abstract][Full Text] [Related]
16. Self-measured home blood pressure in predicting ambulatory hypertension.
Mansoor GA; White WB
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1017-22. PubMed ID: 15533727
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring.
Ben-Dov IZ; Ben-Arie L; Mekler J; Bursztyn M
Int J Cardiol; 2007 May; 117(3):355-9. PubMed ID: 16879886
[TBL] [Abstract][Full Text] [Related]
18. [White-coat hypertension].
Verdecchia P; Porcellati C
G Ital Cardiol; 1995 Jul; 25(7):899-909. PubMed ID: 7557039
[TBL] [Abstract][Full Text] [Related]
19. White coat hypertension and white coat effect. Similarities and differences.
Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Zampi I; Gattobigio R; Sacchi N; Porcellati C
Am J Hypertens; 1995 Aug; 8(8):790-8. PubMed ID: 7576395
[TBL] [Abstract][Full Text] [Related]
20. 'White coat' hypertension in children.
Hornsby JL; Mongan PF; Taylor AT; Treiber FA
J Fam Pract; 1991 Dec; 33(6):617-23. PubMed ID: 1744607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
